Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Lactosylsphingosine is a bioactive sphingolipid and a form of lactosylceramide that is lacking the fatty acyl group. Lyso-lactosylceramide (1-50 μM) reduces viability of human neutrophils in a concentration-dependent manner. Unlike lactosylceramide,lactosylsphingosine has no effect on protein synthesis and cell proliferation in cardiomyocytes. Lactosylsphingosine is a precursor in the synthesis of lyso-ganglioside GM3.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | 35 days | $ 296.00 |
Description | Lactosylsphingosine is a bioactive sphingolipid and a form of lactosylceramide that is lacking the fatty acyl group. Lyso-lactosylceramide (1-50 μM) reduces viability of human neutrophils in a concentration-dependent manner. Unlike lactosylceramide,lactosylsphingosine has no effect on protein synthesis and cell proliferation in cardiomyocytes. Lactosylsphingosine is a precursor in the synthesis of lyso-ganglioside GM3. |
Synonyms | Lactosylsphingosine (d18:1) |
Molecular Weight | 623.77 |
Formula | C30H57NO12 |
CAS No. | 109785-20-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Chloroform:Methanol:H2O (2:1:0.1): Soluble
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Lactosylsphingosine (d18:1) 109785-20-8 Lactosylsphingosine Lactosylsphingosine (d-18:1) d18:1 inhibitor inhibit